We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.40 | 0.20% | 1,708.60 | 1,708.60 | 1,708.80 | 1,713.00 | 1,699.40 | 1,701.60 | 11,522,668 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.27 | 70.34B |
TIDMGSK
RNS Number : 4137F
GlaxoSmithKline PLC
20 February 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Ms E Walmsley === ====================== ====================================== b) Position/status Chief Executive Officer === ====================== ====================================== c) Initial notification/ Initial Notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of The exercise of nil-cost options the transaction over Ordinary Shares granted on 11 February 2015 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) === ====================== ============ ==================== GBP0.0000 12,482 (Deferred) === ====================== ============ ==================== GBP0.0000 8,614 (Matching) ============ ==================== d) Aggregated information === Aggregated 21,096 volume Price GBP0.0000 === ====================== ====================================== e) Date of the 2018-02-16 transaction === ====================== ====================================== f) Place of the n/a transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ================================================================== a) Name Ms E Walmsley === ====================== ========================================== b) Position/status Chief Executive Officer === ====================== ========================================== c) Initial notification/ Initial Notification amendment === ====================== ========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================== a) Name GlaxoSmithKline plc === ====================== ========================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ================================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ========================================== b) Nature of The sale of Ordinary Shares the transaction to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 16 February 2018 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ====================== ========================================== c) Price(s) and Price(s) Volume(s) volume(s) === ====================== =============== ===================== GBP13.1563 5,868 (Deferred) === ====================== =============== ===================== GBP13.1563 4,050 (Matching) =============== ===================== d) Aggregated information === Aggregated 9,918 volume Price GBP13.1563 === ====================== ========================================== e) Date of the 2018-02-16 transaction === ====================== ========================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ========================================== 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================== a) Name Mr R Connor === ======================= ====================================== b) Position/status President, Global Manufacturing & Supply === ======================= ====================================== c) Initial notification/ Initial Notification amendment === ======================= ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================== a) Name GlaxoSmithKline plc === ======================= ====================================== b) LEI 5493000HZTVUYLO1D793 === ======================= ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ======================= ====================================== b) Nature of The exercise of nil-cost options the transaction over Ordinary Shares granted on 11 February 2015 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ======================= ====================================== c) Price(s) and Price(s) Volume(s) volume(s) === ======================= ============ ==================== GBP0.0000 9,142 (Deferred) === ======================= ============ ==================== GBP0.0000 6,308 (Matching) ============ ==================== d) Aggregated information === Aggregated 15,450 volume Price GBP0.0000 === ======================= ====================================== e) Date of the 2018-02-16 transaction === ======================= ====================================== f) Place of the n/a transaction === ======================= ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ================================================================= a) Name Mr R Connor === ======================= ======================================== b) Position/status President, Global Manufacturing & Supply === ======================= ======================================== c) Initial notification/ Initial Notification amendment === ======================= ======================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================= a) Name GlaxoSmithKline plc === ======================= ======================================== b) LEI 5493000HZTVUYLO1D793 === ======================= ======================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ================================================================= a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ======================= ======================================== b) Nature of the The sale of Ordinary Shares transaction to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 16 February 2018 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ======================= ======================================== c) Price(s) and Price(s) Volume(s) volume(s) === ======================= ============== ==================== GBP13.1028 4,384 (Deferred) === ======================= ============== ==================== GBP13.1200 3,026 (Matching) ============== ==================== d) Aggregated information === Aggregated volume 7,410 Price GBP13.1114 === ======================= ======================================== e) Date of the 2018-02-16 transaction === ======================= ======================================== f) Place of the London Stock Exchange (XLON) transaction === ======================= ======================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Mr S Dingemans === ====================== ====================================== b) Position/status Chief Financial Officer === ====================== ====================================== c) Initial notification/ Initial Notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of The exercise of nil-cost options the transaction over Ordinary Shares granted on 11 February 2015 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) === ====================== ============ ==================== GBP0.0000 17,435 (Deferred) === ====================== ============ ==================== GBP0.0000 12,030 (Matching) ============ ==================== d) Aggregated information === Aggregated 29,465 volume Price GBP0.0000 === ====================== ====================================== e) Date of the 2018-02-16 transaction === ====================== ====================================== f) Place of the n/a transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ================================================================= a) Name Mr S Dingemans === ======================= ======================================== b) Position/status Chief Financial Officer === ======================= ======================================== c) Initial notification/ Initial Notification amendment === ======================= ======================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================= a) Name GlaxoSmithKline plc === ======================= ======================================== b) LEI 5493000HZTVUYLO1D793 === ======================= ======================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ================================================================= a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ======================= ======================================== b) Nature of the The sale of Ordinary Shares transaction to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 16 February 2018 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ======================= ======================================== c) Price(s) and Price(s) Volume(s) volume(s) === ======================= ============== ==================== GBP13.1236 8,360 (Deferred) === ======================= ============== ==================== GBP13.1230 5,768 (Matching) ============== ==================== d) Aggregated information === Aggregated volume 14,128 Price GBP13.1233 === ======================= ======================================== e) Date of the 2018-02-16 transaction === ======================= ======================================== f) Place of the London Stock Exchange (XLON) transaction === ======================= ======================================== 1. Details of PDMR/person closely associated with them ('PCA') === ================================================================ a) Name Mr N Hirons === ======================= ======================================= b) Position/status SVP, Global Ethics and Compliance === ======================= ======================================= c) Initial notification/ Initial Notification amendment === ======================= ======================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================ a) Name GlaxoSmithKline plc === ======================= ======================================= b) LEI 5493000HZTVUYLO1D793 === ======================= ======================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ================================================================ a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ======================= ======================================= b) Nature of The exercise of nil-cost options the transaction over Ordinary Shares granted on 11 February 2015 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ======================= ======================================= c) Price(s) and Price(s) Volume(s) volume(s) === ======================= ============= ==================== GBP0.0000 6,402 (Deferred) === ======================= ============= ==================== GBP0.0000 4,418 (Matching) ============= ==================== d) Aggregated information === Aggregated 10,820 volume Price GBP0.0000 === ======================= ======================================= e) Date of the 2018-02-16 transaction === ======================= ======================================= f) Place of the n/a transaction
=== ======================= ======================================= 1. Details of PDMR/person closely associated with them ('PCA') === ================================================================= a) Name Mr N Hirons === ======================= ======================================== b) Position/status SVP, Global Ethics and Compliance === ======================= ======================================== c) Initial notification/ Initial Notification amendment === ======================= ======================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================= a) Name GlaxoSmithKline plc === ======================= ======================================== b) LEI 5493000HZTVUYLO1D793 === ======================= ======================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ================================================================= a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ======================= ======================================== b) Nature of the The sale of Ordinary Shares transaction to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 16 February 2018 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ======================= ======================================== c) Price(s) and Price(s) Volume(s) volume(s) === ======================= ============== ==================== GBP13.1068 3,070 (Deferred) === ======================= ============== ==================== GBP13.1118 2,120 (Matching) ============== ==================== d) Aggregated information === Aggregated volume 5,190 Price GBP13.1093 === ======================= ======================================== e) Date of the 2018-02-16 transaction === ======================= ======================================== f) Place of the London Stock Exchange (XLON) transaction === ======================= ======================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Mr D Redfern === ====================== ====================================== b) Position/status Chief Strategy Officer === ====================== ====================================== c) Initial notification/ Initial Notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of The exercise of nil-cost options the transaction over Ordinary Shares granted on 11 February 2015 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) === ====================== ============ ==================== GBP0.0000 10,258 (Deferred) === ====================== ============ ==================== GBP0.0000 7,078 (Matching) ============ ==================== d) Aggregated information === Aggregated 17,336 volume Price GBP0.0000 === ====================== ====================================== e) Date of the 2018-02-16 transaction === ====================== ====================================== f) Place of the n/a transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ================================================================= a) Name Mr D Redfern === ======================= ======================================== b) Position/status Chief Strategy Officer === ======================= ======================================== c) Initial notification/ Initial Notification amendment === ======================= ======================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================= a) Name GlaxoSmithKline plc === ======================= ======================================== b) LEI 5493000HZTVUYLO1D793 === ======================= ======================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ================================================================= a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ======================= ======================================== b) Nature of the The sale of Ordinary Shares transaction to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 16 February 2018 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ======================= ======================================== c) Price(s) and Price(s) Volume(s) volume(s) === ======================= ============== ==================== GBP13.1800 4,822 (Deferred) === ======================= ============== ==================== GBP13.1800 3,328 (Matching) ============== ==================== d) Aggregated information === Aggregated volume 8,150 Price GBP13.1800 === ======================= ======================================== e) Date of the 2018-02-16 transaction === ======================= ======================================== f) Place of the London Stock Exchange (XLON) transaction === ======================= ======================================== 1. Details of PDMR/person closely associated with them ('PCA') === ============================================================== a) Name Ms C Thomas === ====================== ====================================== b) Position/status SVP, Human Resources === ====================== ====================================== c) Initial notification/ Initial Notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument
ISIN: GB0009252882 === ====================== ====================================== b) Nature of The exercise of nil-cost options the transaction over Ordinary Shares granted on 11 February 2015 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) === ====================== ============ ==================== GBP0.0000 13,805 (Deferred) === ====================== ============ ==================== GBP0.0000 9,525 (Matching) ============ ==================== d) Aggregated information === Aggregated 23,330 volume Price GBP0.0000 === ====================== ====================================== e) Date of the 2018-02-16 transaction === ====================== ====================================== f) Place of the n/a transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ================================================================ a) Name Ms C Thomas === ====================== ======================================== b) Position/status SVP, Human Resources === ====================== ======================================== c) Initial notification/ Initial Notification amendment === ====================== ======================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================ a) Name GlaxoSmithKline plc === ====================== ======================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ======================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ================================================================ a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ======================================== b) Nature of the The sale of Ordinary Shares transaction to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 16 February 2018 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ====================== ======================================== c) Price(s) and Price(s) Volume(s) volume(s) === ====================== ============== ==================== GBP13.1180 6,489 (Deferred) === ====================== ============== ==================== GBP13.1180 4,478 (Matching) ============== ==================== d) Aggregated information === Aggregated 10,967 volume Price GBP13.1180 === ====================== ======================================== e) Date of the 2018-02-16 transaction === ====================== ======================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ======================================== 1. Details of PDMR/person closely associated with them ('PCA') === =============================================================== a) Name Mr P Thomson === ======================= ====================================== b) Position/status President, Global Affairs === ======================= ====================================== c) Initial notification/ Initial Notification amendment === ======================= ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =============================================================== a) Name GlaxoSmithKline plc === ======================= ====================================== b) LEI 5493000HZTVUYLO1D793 === ======================= ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =============================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ======================= ====================================== b) Nature of The exercise of nil-cost options the transaction over Ordinary Shares granted on 11 February 2015 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ======================= ====================================== c) Price(s) and Price(s) Volume(s) volume(s) === ======================= ============ ==================== GBP0.0000 4,689 (Deferred) === ======================= ============ ==================== GBP0.0000 3,235 (Matching) ============ ==================== d) Aggregated information === Aggregated 7,924 volume Price GBP0.0000 === ======================= ====================================== e) Date of the 2018-02-19 transaction === ======================= ====================================== f) Place of the n/a transaction === ======================= ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ================================================================ a) Name Mr P Thomson === ====================== ======================================== b) Position/status President, Global Affairs === ====================== ======================================== c) Initial notification/ Initial Notification amendment === ====================== ======================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================ a) Name GlaxoSmithKline plc === ====================== ======================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ======================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ================================================================ a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ======================================== b) Nature of the The sale of Ordinary Shares transaction to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 19 February 2018 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ====================== ======================================== c) Price(s) and Price(s) Volume(s) volume(s) === ====================== ============== ==================== GBP13.1240 2,204 (Deferred) === ====================== ============== ==================== GBP13.1240 1,521 (Matching) ============== ==================== d) Aggregated information === Aggregated 3,725 volume Price GBP13.1240 === ====================== ======================================== e) Date of the 2018-02-19 transaction === ====================== ======================================== f) Place of the London Stock Exchange (XLON) transaction === ====================== ======================================== 1. Details of PDMR/person closely associated with them ('PCA')
=== ============================================================== a) Name Dr P Vallance === ====================== ====================================== b) Position/status Outgoing President, R&D === ====================== ====================================== c) Initial notification/ Initial Notification amendment === ====================== ====================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ============================================================== a) Name GlaxoSmithKline plc === ====================== ====================================== b) LEI 5493000HZTVUYLO1D793 === ====================== ====================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ============================================================== a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ====================================== b) Nature of The exercise of nil-cost options the transaction over Ordinary Shares granted on 11 February 2015 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ====================== ====================================== c) Price(s) and Price(s) Volume(s) volume(s) === ====================== ============ ==================== GBP0.0000 20,322 (Deferred) === ====================== ============ ==================== GBP0.0000 14,022 (Matching) ============ ==================== d) Aggregated information === Aggregated 34,344 volume Price GBP0.0000 === ====================== ====================================== e) Date of the 2018-02-19 transaction === ====================== ====================================== f) Place of the n/a transaction === ====================== ====================================== 1. Details of PDMR/person closely associated with them ('PCA') === ================================================================= a) Name Dr P Vallance === ====================== ========================================= b) Position/status Outgoing President, R&D === ====================== ========================================= c) Initial notification/ Initial Notification amendment === ====================== ========================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ================================================================= a) Name GlaxoSmithKline plc === ====================== ========================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ========================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ================================================================= a) Description Ordinary shares of 25 pence of the financial each ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ========================================= b) Nature of the The sale of Ordinary Shares transaction following the exercise of options on 19 February 2018 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === ====================== ========================================= c) Price(s) and Price(s) Volume(s) volume(s) === ====================== ============== ===================== GBP13.1760 20,322 (Deferred) === ====================== ============== ===================== GBP13.1760 14,022 (Matching) ============== ===================== d) Aggregated information === Aggregated 34,344 volume Price GBP13.1180 === ====================== ========================================= e) Date of the 2018-02-19 transaction === ====================== ========================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== =========================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHXBLFLVLFFBBL
(END) Dow Jones Newswires
February 20, 2018 08:15 ET (13:15 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions